Lion’s Mane is not proven to treat ALS/MND
You Nutrition Clinic has a commercial interest in this subject. Compass summarises the reporting; it is not independent analysis, and it is not clinical evidence.
Human trials suggest some mushroom products may affect measures such as cognition, but this is not evidence that they slow neurodegenerative disease. For ALS/MND specifically, there is currently insufficient evidence to support Lion’s Mane as a treatment, and ALS-specific research is missing.
Why this matters
People with ALS/MND may encounter claims about medicinal mushrooms online. The evidence discussed here does not show that Lion’s Mane or other mushroom products improve ALS/MND symptoms, slow progression or extend survival. Products also differ by species, preparation, dose and extraction method, so results from one product cannot automatically be applied to another.
Limitations and context
This is a sponsored expert-review article, not a new clinical study. The human trials described mainly involved cognition or subjective cognitive impairment, not people with ALS/MND, and the source notes that tolerability in small studies does not establish suitability for everyone. Larger, ALS-specific studies would be needed to assess safety and effectiveness in ALS/MND.